A Plus Biotechnology Co (ROCO:6918) Total Stockholders Equity : NT$844.8 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Total Stockholders Equity?

A Plus Biotechnology Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$844.8 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. A Plus Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2025 was NT$27.73. The ratio of a company's debt over equity can be used to measure how leveraged this company is. A Plus Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.12.

A Plus Biotechnology Co Total Stockholders Equity Historical Data

The historical data trend for A Plus Biotechnology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Total Stockholders Equity Chart

A Plus Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

768.37

843.94

877.81

827.94

919.05

A Plus Biotechnology Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial								-	865.29	922.21	919.05	844.84

A Plus Biotechnology Co (ROCO:6918) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

A Plus Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(844.841	-	0)	/	30.471
	=	27.73

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

A Plus Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.887	+	90.199)	/	844.841
	=	0.12

A Plus Biotechnology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN

Website

https://www.aplusbio.com

A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines